SCHEMBL25763766

SCHEMBL25763766

CC(C)c1ncc(-c2cccc(F)c2)cc1C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 1/20 0.52
▸ PDGFRB P09619 1/20 0.42
▸ PDGFRA P16234 1/20 0.42
▸ NR1H3 Q13133 3/20 0.40
▸ NR1H2 P55055 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ GRIN2B Q13224 2/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ NT5E P21589 2/20 0.38
▸ FYN P06241 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ GCGR P47871 1/20 0.38
▸ PDE3B Q13370 2/20 0.37
▸ PDE3A Q14432 2/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ GRIN1 Q05586 1/20 0.36
▸ GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25764075 0.87 AR (0.49) CYP11B2NR1H3NR1H2ALDH1A1GAA
SCHEMBL25764079 0.86 ESR1 (0.39) CYP11B2NR1H3NR1H2
SCHEMBL25764072 0.86 MAP4K4 (0.40) CYP11B2NR1H3NR1H2ALDH1A1GAA
SCHEMBL25763768 0.85 PGR (0.53) CYP11B2PDGFRBPDGFRANR1H3NR1H2
SCHEMBL25763772 0.83 FYN (0.43) CYP11B2NR1H3NR1H2ALDH1A1GAA
SCHEMBL25763769 0.83 KCNH2 (0.48) NR1H3NR1H2GRIN2BGRIN1
SCHEMBL25764092 0.81 CYP11B2 (0.47) CYP11B2PDGFRBPDGFRAGRIN2BIDO1
SCHEMBL25763803 0.80 PIK3CD (0.37) CYP11B2NR1H3NR1H2GRIN2B
SCHEMBL21419075 0.77 TRPA1 (0.33) CYP11B2NR1H3NR1H2
SCHEMBL25764094 0.75 ALDH1A1 (0.53) ALDH1A1GAAATMGRIN2BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116835-A1 MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON 苏州开拓药业股份有限公司 2023-06-29 — — WO disclosed
Send feedback